New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (359)	12/31/2001 11:36:53 AM
From: richardred	of 724

Takout Speculation by foreign interests to- VWR SCIENTIFIC-Merck Sells Minority Stake in PRI For More Than EUR 400 Million Merck KGaA announced today that it has entered into binding agreements with a number of investors to sell its 43 percent stake in the U.S. generic drug manufacturer Pharmaceutical Resources Inc. (PRI) in a private placement for $27 per share or a total of more than EUR 400 million. Profit after tax for the Merck Group will be approximately EUR 250 million. ”Merck’s investment in Pharmaceutical Resources has proven very profitable within just three years,” said Prof. Bernhard Scheuble, chairman and chief executive of Merck KGaA. ”We intend to use the proceeds to expand our pharma activities. Merck also remains very committed to expanding its direct presence in the U.S.” Both the U.S. market and generics remain core activities of the Merck Group >> Press Release Infos: Phyllis Carter Federico Hernández-Meyer / 22.08.2001 IMO-Lab supplies is a Business they would like a greater presants in the US. RR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next